Get access

Erythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient data

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

1. To examine the effect of ESAs on overall survival, progression free survival, thromboembolic and cardiovascular events as well as need for transfusions and other important safety and efficacy outcomes in cancer patients.

2. To identify factors that modify the effect of ESAs on overall survival, progression free survival, thromboembolic and cardiovascular events, need for transfusions and other important safety and efficacy outcomes in cancer patients.

Get access to the full text of this article

Ancillary